LTX-315 Completed Phase 1 Trials for Triple-Negative Breast Cancer (TNBC) / Malignancies / Cancer, Breast / Melanoma / Malignant Lymphomas / Head and Neck Carcinoma Treatment

IndicationsStatusPurposePhase
CompletedTreatment1
clinicaltrials.gov IdentifierTitleDrugs
NCT01986426LTX-315 in Patients With Transdermally Accessible Tumours as Monotherapy or Combination With Ipilimumab or Pembrolizumab